Document Detail

Anaphylaxis to intravenous amiodarone.
MedLine Citation:
PMID:  15675221     Owner:  NLM     Status:  MEDLINE    
Amiodarone, a class III antiarrhythmic, has been widely used to treat both ventricular and supraventricular arrhythmias. Despite the multitude of side-effects seen with this drug, no case of amiodarone anaphylaxis (confirmed by mast cell tryptase levels and skin testing) has been reported in the medical literature. We report a case of anaphylaxis to intravenous amiodarone in a 77-year-old patient.
S Fransi; J Briedis
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Anaesthesia and intensive care     Volume:  32     ISSN:  0310-057X     ISO Abbreviation:  Anaesth Intensive Care     Publication Date:  2004 Aug 
Date Detail:
Created Date:  2005-01-28     Completed Date:  2005-04-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0342017     Medline TA:  Anaesth Intensive Care     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  578-9     Citation Subset:  IM    
Department of Anaesthesia and Perioperative Medicine, The Northern Hospital, Melbourne, Victoria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amiodarone / administration & dosage,  adverse effects*
Anaphylaxis / chemically induced*,  therapy
Anti-Arrhythmia Agents / administration & dosage,  adverse effects*
Infusions, Intravenous
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 1951-25-3/Amiodarone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Tramadol overdose and serotonin syndrome manifesting as acute right heart dysfunction.
Next Document:  Reductions in levels of bacterial superantigens/cannabinoids by plasma exchange in a patient with se...